3D collagen type I matrix inhibits the antimigratory effect of doxorubicin

Cancer Cell International

Volumn 10, Issue , 2010, Pages

  Millerot Serrurot, Emilie ^a   Guilbert, Marie ^a   Fourré, Nicolas ^a   Witkowski, Wojciech ^a   Said, Georges ^a   Van Gulick, Laurence ^a   Terryn, Christine ^b   Zahm, Jean Marie ^c   Garnotel, Roselyne ^a   Jeannesson, Pierre ^a  

^a CNRS   (France)

^b IFR 53   (France)

^c HÔPITAL MAISON BLANCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; COLLAGEN TYPE 1; DOXORUBICIN; FOCAL ADHESION KINASE; GUANOSINE TRIPHOSPHATASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL MOTION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FOCAL ADHESION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PHENOTYPE; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 77955484541     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-10-26     Document Type: Article

References (31)

1. Dong F, Budhu AS, Wang XW. Translating the metastasis paradigm from scientific theory to clinical oncology. Clin Cancer Res 2009, 15(8):2588-2593. 10.1158/1078-0432.CCR-08-2356, 2683353, 19351761.
2. Perez L, Danishefsky SJ. Chemistry and biology in search of antimetastatic agents. ACS Chem Biol 2007, 2(3):159-162. 10.1021/cb7000395, 17373763.
3. Simunek T, Sterba M, Popelova O, Adamcova M, Hrdina R, Gersl V. Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep 2009, 61(1):154-171.
4. Fourre N, Millerot-Serrurot E, Garnotel R, Zahm JM, Bonnet N, Millot JM, Jeannesson P. Extracellular matrix proteins protect human HT1080 cells against the antimigratory effect of doxorubicin. Cancer Sci 2008, 99(8):1699-1705. 10.1111/j.1349-7006.2008.00876.x, 18754886.
5. Doillon CJ, Gagnon E, Paradis R, Koutsilieris M. Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity. Anticancer Res 2004, 24(4):2169-2177.
6. Addadi-Rebbah S, Poitevin S, Fourre N, Polette M, Garnotel R, Jeannesson P. Assessment of the antiinvasive potential of the anthracycline aclacinomycin (Aclarubicin) in a human fibrosarcoma cell line. Int J Oncol 2004, 24(6):1607-1615.
7. Park HJ, Chung HJ, Min HY, Park EJ, Hong JY, Kim WB, Kim SH, Lee SK. Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases. Biochem Pharmacol 2005, 71(1-2):21-31. 10.1016/j.bcp.2005.10.007, 16271263.
8. Repesh LA, Drake SR, Warner MC, Downing SW, Jyring R, Seftor EA, Hendrix MJ, McCarthy JB. Adriamycin-induced inhibition of melanoma cell invasion is correlated with decreases in tumor cell motility and increases in focal contact formation. Clin Exp Metastasis 1993, 11(1):91-102. 10.1007/BF00880070, 8422710.
9. Meads MB, Gatenby RA, Dalton WS. Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer 2009, 9(9):665-674. 10.1038/nrc2714, 19693095.
10. Serebriiskii I, Castello-Cros R, Lamb A, Golemis EA, Cukierman E. Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells. Matrix Biol 2008, 27(6):573-585. 10.1016/j.matbio.2008.02.008, 2603546, 18411046.
11. Mao Y, Schwarzbauer JE. Stimulatory effects of a three-dimensional microenvironment on cell-mediated fibronectin fibrillogenesis. J Cell Sci 2005, 118(Pt 19):4427-4436. 10.1242/jcs.02566, 16159961.
12. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, Chilvers ER, Dransfield I, Donnelly SC, Strieter R, et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 1999, 5(6):662-668. 10.1038/9511, 10371505.
13. Berube M, Talbot M, Collin C, Paquet-Bouchard C, Germain L, Guerin SL, Petitclerc E. Role of the extracellular matrix proteins in the resistance of SP6.5 uveal melanoma cells toward cisplatin. Int J Oncol 2005, 26(2):405-413.
14. Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 2006, 7(3):211-224. 10.1038/nrm1858, 16496023.
15. Zhao J, Guan JL. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 2009, 28(1-2):35-49. 10.1007/s10555-008-9165-4, 19169797.
16. Hall A. The cytoskeleton and cancer. Cancer Metastasis Rev 2009, 28(1-2):5-14. 10.1007/s10555-008-9166-3, 19153674.
17. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004, 56(2):185-229. 10.1124/pr.56.2.6, 15169927.
18. Ramanujan S, Pluen A, McKee TD, Brown EB, Boucher Y, Jain RK. Diffusion and convection in collagen gels: implications for transport in the tumor interstitium. Biophys J 2002, 83(3):1650-1660. 10.1016/S0006-3495(02)73933-7, 1302261, 12202388.
19. Fourre N, Millot JM, Garnotel R, Jeannesson P. In situ analysis of doxorubicin uptake and cytotoxicity in a 3D culture model of human HT-1080 fibrosarcoma cells. Anticancer Res 2006, 26(6B):4623-4626.
20. Sabeh F, Shimizu-Hirota R, Weiss SJ. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol 2009, 185(1):11-19. 10.1083/jcb.200807195, 2700505, 19332889.
21. Sato K, Ebihara T, Adachi E, Kawashima S, Hattori S, Irie S. Possible involvement of aminotelopeptide in self-assembly and thermal stability of collagen I as revealed by its removal with proteases. J Biol Chem 2000, 275(33):25870-25875. 10.1074/jbc.M003700200, 10851240.
22. Van Goethem E, Poincloux R, Gauffre F, Maridonneau-Parini I, Le Cabec V. Matrix architecture dictates three-dimensional migration modes of human macrophages: differential involvement of proteases and podosome-like structures. J Immunol 184(2):1049-1061. 10.4049/jimmunol.0902223, 20018633.
23. Rhee S, Jiang H, Ho CH, Grinnell F. Microtubule function in fibroblast spreading is modulated according to the tension state of cell-matrix interactions. Proc Natl Acad Sci USA 2007, 104(13):5425-5430. 10.1073/pnas.0608030104, 1838480, 17369366.
24. Yamamoto N, Yang M, Jiang P, Tsuchiya H, Tomita K, Moossa AR, Hoffman RM. Real-time GFP imaging of spontaneous HT-1080 fibrosarcoma lung metastases. Clin Exp Metastasis 2003, 20(2):181-185. 10.1023/A:1022662927574, 12705639.
25. Hazgui S, Bonnet N, Cutrona J, Nawrocki-Raby B, Polette M, Chouchane L, Birembaut P, Zahm JM. 3D culture model and computer-assisted videomicroscopy to analyze migratory behavior of noninvasive and invasive bronchial epithelial cells. Am J Physiol Cell Physiol 2005, 289(6):C1547-1552. 10.1152/ajpcell.00319.2005, 16033905.
26. Morin PJ. Drug resistance and the microenvironment: nature and nurture. Drug Resist Updat 2003, 6(4):169-172. 10.1016/S1368-7646(03)00059-1, 12962682.
27. Pupa SM, Giuffre S, Castiglioni F, Bertola L, Cantu M, Bongarzone I, Baldassari P, Mortarini R, Argraves WS, Anichini A, et al. Regulation of breast cancer response to chemotherapy by fibulin-1. Cancer Res 2007, 67(9):4271-4277. 10.1158/0008-5472.CAN-06-4162, 17483339.
28. Lee SC, Xu X, Lim YW, Iau P, Sukri N, Lim SE, Yap HL, Yeo WL, Tan P, Tan SH, et al. Chemotherapy-induced tumor gene expression changes in human breast cancers. Pharmacogenet Genomics 2009, 19(3):181-192. 10.1097/FPC.0b013e32831ebb5d, 19352302.
29. van Nimwegen MJ, van de Water B. Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol 2007, 73(5):597-609. 10.1016/j.bcp.2006.08.011, 16997283.
30. Garnotel R, Rittie L, Poitevin S, Monboisse JC, Nguyen P, Potron G, Maquart FX, Randoux A, Gillery P. Human blood monocytes interact with type I collagen through alpha × beta 2 integrin (CD11 c-CD18, gp150-95). J Immunol 2000, 164(11):5928-5934.
31. DesMarais V, Ichetovkin I, Condeelis J, Hitchcock-DeGregori SE. Spatial regulation of actin dynamics: a tropomyosin-free, actin-rich compartment at the leading edge. J Cell Sci 2002, 115(Pt 23):4649-4660. 10.1242/jcs.00147, 12415009.